References
- Marrouche NF, Wilber D, Hindricks G, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014;311(5):498–506.
- Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. J Arrhythm. 2017;33(5):369–409.
- Mohanty S, Mohanty P, Di Biase L, et al. Long-term follow-up of patients with paroxysmal atrial fibrillation and severe left atrial scarring: comparison between pulmonary vein antrum isolation only or pulmonary vein isolation combined with either scar homogenization or trigger ablation. Europace. 2017;19(11):1790–1797.
- Schreiber D, Rieger A, Moser F, et al. Catheter ablation of atrial fibrillation with box isolation of fibrotic areas: Lessons on fibrosis distribution and extent, clinical characteristics, and their impact on long-term outcome. J Cardiovasc Electrophysiol. 2017;28(9):971–983.
- Dilaveris PE, Gialafos EJ, Sideris SK, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J Mosby Inc. 1998;135(5):733–738.
- Perzanowski C, Ho AT, Jacobson AK. Increased P-wave dispersion predicts recurrent atrial fibrillation after cardioversion. J Electrocardiol. 2005;38(1):43–46.
- Kizilirmak F, Demir GG, Gokdeniz T, Gunes HM, et al. Changes in electrocardiographic P wave parameters after cryoballoon ablation and their association with atrial fibrillation recurrence. Ann Noninvasive Electrocardiol. 2016;21(6):580–587.
- Marcus GM, Yang Y, Varosy PD, et al. Regional left atrial voltage in patients with atrial fibrillation. Hear Rhythm. 2007;4(2):138–144.
- Yamaguchi T, Tsuchiya T, Nakahara S, et al. Efficacy of left atrial Voltage-Based catheter ablation of persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27(9):1055–1063.
- Rolf S, Kircher S, Arya A, et al. Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7(5):825–833.
- Çamsari A, Pekdemir H, Akkus MN, et al. Long-term effects of beta blocker therapy on P-wave duration and dispersion in congestive heart failure patients: a new effect? J Electrocardiol. 2003;36(2):111–116.
- Erbay AR, Turhan H, Yasar AS, et al. Effects of long-term beta-blocker therapy on P-wave duration and dispersion in patients with rheumatic mitral stenosis. Int J Cardiol. 2005; 102:33–37.
- Burashnikov A, Di Diego JM, Sicouri S, et al. Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation. Hear Rhythm. 2008;5(12):1735–1742.
- Sim I, Bishop M, O’Neill M, et al. Left atrial voltage mapping: defining and targeting the atrial fibrillation substrate. J Interv Card Electrophysiol. 2019;56(3):213–227.
- Cheema A, Dong J, Dalal D, et al. Incidence and time course of early recovery of pulmonary vein conduction after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18(4):387–391.
- Malcolme-Lawes LC, Juli C, Karim R, et al. Automated analysis of atrial late gadolinium enhancement imaging that correlates with endocardial voltage and clinical outcomes: a 2-center study. Hear Rhythm Elsevier B.V. 2013;10(8):1184–1191.
- Verma A, Wazni OM, Marrouche NF, et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol. 2005;45(2):285–292.
- Dilaveris PE, Gialafos EJ, Andrikopoulos GK, et al. Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pacing Clin Electro. 2000;23(3):352–358.